title: Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
authors.affiliation: Abteilung Nephrologie, Medizinische Hochschule, Hannover, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: C
authors.initials: C
authors.lastname: Wanner
authors.forename: T
authors.initials: T
authors.lastname: Eisenhauer
authors.forename: C J
authors.initials: CJ
authors.lastname: Olbricht
authors.forename: R
authors.initials: R
authors.lastname: Doll
authors.forename: M
authors.initials: M
authors.lastname: Boddaert
authors.forename: P
authors.initials: P
authors.lastname: O'Grady
authors.forename: M
authors.initials: M
authors.lastname: Krekler
authors.forename: B
authors.initials: B
authors.lastname: Mangold
authors.forename: U
authors.initials: U
authors.lastname: Christians
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008148:Lovastatin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D017035:Pravastatin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin; D017035:Pravastatin